Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus-host disease

被引:40
作者
Nichols, WC
Antin, JH
Lunetta, KL
Tarry, VH
Hertel, CE
Wheatley, MA
Arnold, ND
Siemieniak, DR
Boehnke, M
Ginsburg, D
机构
[1] UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,MED CTR,DEPT BIOSTAT,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,MED CTR,DEPT HUMAN GENET,ANN ARBOR,MI 48109
[4] UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109
[5] BRIGHAM & WOMENS HOSP,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02115
关键词
D O I
10.1182/blood.V88.12.4429.bloodjournal88124429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mismatch between bone marrow transplant (BMT) patient and donor for an amino acid polymorphism within the adhesion molecule CD31 has recently been reported to increase risk for the development of graft-versus-host disease (GVHD), We further examined this association in a larger series of 301 BMT patients (227 with grade III/IV GVHD and 74 with grade 0 GVHD) and their HLA-identical sibling donors. CD31 genotypes were determined by polymerase chain reaction and restriction endonuclease digestion, The role of mismatch at the CD31 locus in the development of GVHD was assessed by analyzing the extent of CD31 identity and CD31 compatibility among the grade 0 GVHD and grade III/IV GVHD sibling pairs. No significant association between CD31 mismatch and the development of severe GVHD was detected in our overall patient population. sixty-three percent of grade III/IV GVHD sibling pairs and 69% of grade 0 GVHD sibling pairs had CD31 genotypes that were identical (P = .36, odds ratio = 1.30), In addition, neither the grade 0 GVHD group (P = .10) nor the grade III/IV GVHD group (P = .27) differed significantly from the expected probability of identity between sibling pairs. Mismatch at the CD31 polymorphism between recipients and donors showed no consistent association with the development of GVHD. Current evidence does not support the value of CD31 mismatch in the selection of BMT donors. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:4429 / 4434
页数:6
相关论文
共 31 条
[1]  
Agresti A., 1990, Analysis of categorical data
[2]   MOLECULAR AND CELLULAR PROPERTIES OF PECAM-1 (ENDOCAM/CD31) - A NOVEL VASCULAR CELL CELL-ADHESION MOLECULE [J].
ALBELDA, SM ;
MULLER, WA ;
BUCK, CA ;
NEWMAN, PJ .
JOURNAL OF CELL BIOLOGY, 1991, 114 (05) :1059-1068
[3]  
BEATTY PG, 1993, BLOOD, V81, P249
[4]  
Behar E, 1996, NEW ENGL J MED, V334, P286, DOI 10.1056/NEJM199602013340502
[5]  
BOEHNKE M, 1991, AM J HUM GENET, V48, P22
[6]   TISSUE TYPING THE HLA-A LOCUS FROM GENOMIC DNA BY SEQUENCE-SPECIFIC PCR - COMPARISON OF HLA GENOTYPE AND SURFACE EXPRESSION ON COLORECTAL TUMOR-CELL LINES [J].
BROWNING, MJ ;
KRAUSA, P ;
ROWAN, A ;
BICKNELL, DC ;
BODMER, JG ;
BODMER, WF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2842-2845
[7]   CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINE AND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE [J].
CHAO, NJ ;
SCHMIDT, GM ;
NILAND, JC ;
AMYLON, MD ;
DAGIS, AC ;
LONG, GD ;
NADEMANEE, AP ;
NEGRIN, RS ;
ODONNELL, MR ;
PARKER, PM ;
SMITH, EP ;
SNYDER, DS ;
STEIN, AS ;
WONG, RM ;
BLUME, KG ;
FORMAN, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (17) :1225-1230
[8]   IDENTIFICATION OF A GRAFT-VERSUS-HOST DISEASE-ASSOCIATED HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN [J].
DENHAAN, JMM ;
SHERMAN, NE ;
BLOKLAND, E ;
HUCZKO, E ;
KONING, F ;
DRIJFHOUT, JW ;
SKIPPER, J ;
SHABANOWITZ, J ;
HUNT, DF ;
ENGELHARD, VH ;
GOULMY, E .
SCIENCE, 1995, 268 (5216) :1476-1480
[9]  
DYER PA, 1992, NEPHROL DIAL TRANSPL, V7, P42
[10]  
FERRARA JLM, 1991, NEW ENGL J MED, V324, P667